Thesis (Master's)--University of Washington, 2014Purpose: Current guidelines recommend routine imaging surveillance for non-small cell lung cancer (NSCLC) patients following treatment. Little is known about surveillance patterns for surgically resected, early-stage lung cancer patients in the community-at-large. We sought to characterize surveillance patterns in a national cohort. Methods: We conducted a retrospective study using Surveillance, Epidemiology, and End-Results (SEER)-Medicare database (1995-2010). Patients with stage I/II NSCLC treated with surgical resection were included. Our primary outcome was receipt of imaging between 4 and 8 months following surgery. Covariates included demographics and comorbidities. Results: Chest ra...
PurposeUncertainty exists regarding the optimal surveillance imaging strategy following stereotactic...
OBJECTIVE: Surgery for early stage non-small cell lung cancer can be curative. A delay from diagnosi...
Background: The Lung Cancer Screening Trial (NLST) demonstrated improved overall survival (OS) and l...
PURPOSE: Imaging after stereotactic ablative radiation therapy (SABR) for early-stage non-small cell...
INTRODUCTION: Surveillance with computed tomography (CT) imaging following curative treatment of sta...
PURPOSE: Lung cancer screening saves lives, but implementation is challenging. We evaluated two appr...
ObjectiveWe sought to determine the prevalence of defined abnormalities on surveillance computed tom...
Lung cancer is the leading cause of cancer death worldwide. Recurrence rates at all stages are high,...
ObjectiveAt present, there is no consensus on the optimal strategy for follow-up care after curative...
INTRODUCTION: Reducing lung cancer deaths through early detection by computed tomography (CT) screen...
Background The effects of low-dose CT screening on disease stage shift, mortality and overdiagnosis ...
Although pretreatment evaluations are well defined for the diagnosis of radically treatable NSCLC, w...
Background: With preventive screening, increased focus on early detection, and advances in treatment...
BACKGROUND:: Pathologic nodal stage is the key prognostic factor in resectable non-small-cell lung c...
RATIONALE: Lung cancer screening using computed tomography (CT) is effective in detecting lung canc...
PurposeUncertainty exists regarding the optimal surveillance imaging strategy following stereotactic...
OBJECTIVE: Surgery for early stage non-small cell lung cancer can be curative. A delay from diagnosi...
Background: The Lung Cancer Screening Trial (NLST) demonstrated improved overall survival (OS) and l...
PURPOSE: Imaging after stereotactic ablative radiation therapy (SABR) for early-stage non-small cell...
INTRODUCTION: Surveillance with computed tomography (CT) imaging following curative treatment of sta...
PURPOSE: Lung cancer screening saves lives, but implementation is challenging. We evaluated two appr...
ObjectiveWe sought to determine the prevalence of defined abnormalities on surveillance computed tom...
Lung cancer is the leading cause of cancer death worldwide. Recurrence rates at all stages are high,...
ObjectiveAt present, there is no consensus on the optimal strategy for follow-up care after curative...
INTRODUCTION: Reducing lung cancer deaths through early detection by computed tomography (CT) screen...
Background The effects of low-dose CT screening on disease stage shift, mortality and overdiagnosis ...
Although pretreatment evaluations are well defined for the diagnosis of radically treatable NSCLC, w...
Background: With preventive screening, increased focus on early detection, and advances in treatment...
BACKGROUND:: Pathologic nodal stage is the key prognostic factor in resectable non-small-cell lung c...
RATIONALE: Lung cancer screening using computed tomography (CT) is effective in detecting lung canc...
PurposeUncertainty exists regarding the optimal surveillance imaging strategy following stereotactic...
OBJECTIVE: Surgery for early stage non-small cell lung cancer can be curative. A delay from diagnosi...
Background: The Lung Cancer Screening Trial (NLST) demonstrated improved overall survival (OS) and l...